Microdosing and pet studies in drug transporter research
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: SUGIYAMA, Yuichi (RIKEN Innovation Center, Tokyo, Japan)
Microdose clinical trials can be utilized for the purpose to gain pharmacokinetic information on a tentative drug candidate in human using labelled compound(s) and AMS or imaging technology using PET, or non-labelled compound(s) and LC/MS/MS, and to select drug candidate by ensuring adequate properties in early stage. Recently (2008-2012), the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.